Northern Trust
IDYA icon

Northern Trust’s IDEAYA Biosciences IDYA Stock Holding History

Northern Trust’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30M Buy
804,118
+69,997
+10% +$2.14M ﹤0.01% 1553
2026
Q1 		$24.5M Buy
734,121
+58,998
+9% +$1.98M ﹤0.01% 1551
2025
Q4 		$23.3M Sell
675,123
-34,738
-5% -$1.11M ﹤0.01% 1564
2025
Q3 		$19.3M Sell
709,861
-5,495
-0.8% -$133K ﹤0.01% 1712
2025
Q2 		$15M Sell
715,356
-38,173
-5% -$732K ﹤0.01% 1825
2025
Q1 		$12.3M Sell
753,529
-18,323
-2% -$390K ﹤0.01% 1918
2024
Q4 		$19.8M Buy
771,852
+484
+0.1% +$13.7K ﹤0.01% 1688
2024
Q3 		$24.4M Buy
771,368
+130,703
+20% +$4.96M ﹤0.01% 1497
2024
Q2 		$22.5M Sell
640,665
-2,803
-0.4% -$111K ﹤0.01% 1480
2024
Q1 		$28.2M Buy
643,468
+32,459
+5% +$1.4M ﹤0.01% 1358
2023
Q4 		$21.7M Buy
611,009
+49,641
+9% +$1.48M ﹤0.01% 1559
2023
Q3 		$15.1M Buy
561,368
+19,380
+4% +$491K ﹤0.01% 1732
2023
Q2 		$12.7M Buy
541,988
+137,485
+34% +$2.83M ﹤0.01% 1885
2023
Q1 		$5.55M Buy
404,503
+174
+0% +$2.9K ﹤0.01% 2398
2022
Q4 		$7.35M Buy
404,329
+83,821
+26% +$1.41M ﹤0.01% 2223
2022
Q3 		$4.78M Sell
320,508
-8,143
-2% -$106K ﹤0.01% 2513
2022
Q2 		$4.54M Buy
328,651
+26,082
+9% +$290K ﹤0.01% 2581
2022
Q1 		$3.39M Sell
302,569
-9,856
-3% -$145K ﹤0.01% 2812
2021
Q4 		$7.39M Buy
312,425
+3,681
+1% +$85.5K ﹤0.01% 2453
2021
Q3 		$7.87M Buy
308,744
+47,870
+18% +$1.12M ﹤0.01% 2448
2021
Q2 		$5.47M Buy
260,874
+90,729
+53% +$1.86M ﹤0.01% 2788
2021
Q1 		$4M Sell
170,145
-30,300
-15% -$585K ﹤0.01% 2881
2020
Q4 		$2.81M Buy
200,445
+29,943
+18% +$406K ﹤0.01% 3011
2020
Q3 		$2.14M Buy
170,502
+41,635
+32% +$516K ﹤0.01% 3032
2020
Q2 		$1.83M Buy
+128,867
New +$1.02M ﹤0.01% 3083

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Northern Trust's IDYA Position: Q2 2026 in Review

Northern Trust increased its IDEAYA Biosciences (IDYA) stake by 9.5% in Q2 2026, buying an estimated $2.14M and bringing the position to 804,118 shares worth $30M. The position accounts for ﹤0.01% of the portfolio, ranked #1553.

Northern Trust first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Northern Trust held 804,118 shares of IDEAYA Biosciences worth $30M as of Q2 2026.
  • Northern Trust bought 69,997 IDEAYA Biosciences shares in Q2 2026, an estimated $2.14M.
  • IDEAYA Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1553 holding.
  • Northern Trust first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.